MET
64
-2
DOW
40
-7
TXT
65
-3
THC
64
3
MTCH
39
4
CVS
52
-6
CMCSA
53
4
AVGO
37
-10
UNH
41
-14
MMM
45
-2
FDX
27
-3
BWA
59
-5
NTAP
61
-4
GRMN
46
-2
BLK
73
-2
PEP
57
-2
PEG
46
-7
JNPR
60
4
EQIX
65
7
FFIV
61
-5
MET
64
-2
DOW
40
-7
TXT
65
-3
THC
64
3
MTCH
39
4
CVS
52
-6
CMCSA
53
4
AVGO
37
-10
UNH
41
-14
MMM
45
-2
FDX
27
-3
BWA
59
-5
NTAP
61
-4
GRMN
46
-2
BLK
73
-2
PEP
57
-2
PEG
46
-7
JNPR
60
4
EQIX
65
7
FFIV
61
-5
Financhill
Back

Praxis Precision Medicines Vs. Protagonist Therapeutics Industry Stock Comparison

Sell
42

PRAX
Praxis Precision Medicines

Last Price:
72.06
Seasonality Move:
71.13%
Buy
56

PTGX
Protagonist Therapeutics

Last Price:
47.63
Seasonality Move:
13.55%
Sell
42
Praxis Precision Medicines (PRAX) is a Sell

Is Praxis Precision Medicines a Buy, Sell or Hold?

  • The current Praxis Precision Medicines [PRAX] share price is $71.92. The Score for PRAX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • PRAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Protagonist Therapeutics (PTGX) is a Buy

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $47.64. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PRAX Stock Price Chart

What is Praxis Precision Medicines's stock price today?

  • The Praxis Precision Medicines share price today is $71.92
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $47.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.

PRAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.99 Buy
Relative Strength Index (14 RSI): 68.25 Buy
Chaikin Money Flow: 316903 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.32 - 65.3) Buy
Bollinger Bands (100): (44.02 - 60.28) Buy

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 65.65 Buy
Chaikin Money Flow: 126936 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.19 - 46.41) Buy
Bollinger Bands (100): (33.39 - 44.11) Buy

PRAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.55 Buy
20-day SMA: 62.01 Buy
50-day SMA: 57.48 Buy
200-day SMA: 49.51 Buy
8-day EMA: 66.19 Buy
20-day EMA: 62.85 Buy
50-day EMA: 58.66 Buy
200-day EMA: 48.81 Buy

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.87 Buy
20-day SMA: 45.2 Buy
50-day SMA: 43.19 Buy
200-day SMA: 33.03 Buy
8-day EMA: 45.46 Buy
20-day EMA: 44.91 Buy
50-day EMA: 42.95 Buy
200-day EMA: 34.35 Buy

Praxis Precision Medicines Earnings Growth & PRAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.92 per share, and a decrease next year of $0.31 per share.

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.

Praxis Precision Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):